brainstrust brain tumour charity

Brain tumour clinical trials available for:
Anaplastic glioma

Relates to tumour types Title of Research Description More information
Glioma
Glioblastoma
Astrocytoma
Anaplastic oligodendroglioma
Anaplastic glioma
Anaplastic astrocytoma
MR characterisation of invasive phenotypes in GBMs (Study ID: 8596) High grade gliomas are aggressive tumours that are usually rapidly fatal despite intensive treatment. If we could identify patients with limited spread, they might be... read more
Schwannoma
Pituitary
Paediatric
Brain metastases
Neuroblastoma
oligoastrocytoma
Ependymoma
Meningioma
Medulloblastoma
Glioma
Glioblastoma
Astrocytoma
Anaplastic oligodendroglioma
Anaplastic glioma
Anaplastic astrocytoma
VoxTox - Linking radiation dose at the voxel level with toxicity (Study ID: 13716) An observational study to collect detailed information about side effects for patients undergoing image-guided intensity-modulated radiotherapy to the head and neck,... read more
Glioma
Glioblastoma
Anaplastic oligodendroglioma
Anaplastic glioma
Anaplastic astrocytoma
Imaging in Transforming Gliomas (Study ID: 17381) Gliomas are the commonest type of primary brain tumours accounting for approximately 70% of primary brain tumours in adults. Gliomas can be classified into two main... read more
Schwannoma
Pituitary
Brain metastases
Neuroblastoma
oligoastrocytoma
Ependymoma
Meningioma
Medulloblastoma
Glioma
Glioblastoma
Astrocytoma
Anaplastic oligodendroglioma
Anaplastic glioma
Anaplastic astrocytoma
Wrist Worn Trackers for monitoring physical activity in brain tumour patients (Study ID: 38629) Most patient with brain tumours develop functional disturbance (weakness, balance problems, etc.) as part of their illness, and report fatigue as being a significant... read more
Schwannoma
Pituitary
Brain metastases
Neuroblastoma
oligoastrocytoma
Ependymoma
Meningioma
Medulloblastoma
Glioma
Glioblastoma
Astrocytoma
Anaplastic oligodendroglioma
Anaplastic glioma
Anaplastic astrocytoma
MOLGEN – Molecular Genetics of Adverse Drug Reactions (Study ID: 8630) Adverse drug reactions (ADR's) are a common cause of drug-related morbidity and may account for about 6.5% of all hospital admissions. A meta-analysis of studies... read more
Schwannoma
Pituitary
Brain metastases
Neuroblastoma
oligoastrocytoma
Ependymoma
Meningioma
Medulloblastoma
Glioma
Glioblastoma
Astrocytoma
Anaplastic oligodendroglioma
Anaplastic glioma
Anaplastic astrocytoma
Establishing multipotent stem cell lines from CNS tumours (Study ID: 32706) A striking feature of some central nervous system (CNS) tumours is the presence of cell types indicative of mixed neural/glial and mesodermal/mesenchymal (e.g.... read more
Anaplastic astrocytoma
Anaplastic glioma
Anaplastic oligodendroglioma
Astrocytoma
Glioblastoma
Glioma
Medulloblastoma
Meningioma
Ependymoma
oligoastrocytoma
Neuroblastoma
Brain metastases
Pituitary
Schwannoma
Hyperpolarised 13C-Pyruvate MRI study (Study ID: 34177) Metabolic changes related to disease are the precursor to anatomical changes in tissues. Currently our imaging methods routinely used in clinical practice look at the... read more
Anaplastic glioma
Anaplastic oligodendroglioma
Glioblastoma
Glioma
Glutamate Dysfunction in Gliomas, V1.0 (Study ID: 35345) Seizures are a frequent and serious problem for patients with brain tumours and are often not controlled with current best medical and surgical treatments. There are... read more
Anaplastic glioma
Anaplastic oligodendroglioma
Glioblastoma
Glioma
Tissue-type MRI of brain tumours (Study ID: 35807) Gliomas are the most common primary brain tumour. They can be “high-grade” with rapid growth and short patient survival times, or “low-grade” with very slow... read more
Anaplastic astrocytoma
Anaplastic glioma
Anaplastic oligodendroglioma
Astrocytoma
Glioblastoma
Glioma
Medulloblastoma
Meningioma
Ependymoma
oligoastrocytoma
Neuroblastoma
Brain metastases
Pituitary
Schwannoma
Identifying the origin of circulating DNA to detect and diagnose neuro (Study ID: 36279) Damaged and dying cells release DNA into the circulation. This circulating, cell-free DNA (cfDNA) can be easily detected in blood and other bodily fluids such as... read more
Anaplastic astrocytoma
Anaplastic glioma
Anaplastic oligodendroglioma
Astrocytoma
Glioblastoma
Glioma
Medulloblastoma
Meningioma
Ependymoma
oligoastrocytoma
Neuroblastoma
Brain metastases
Pituitary
Schwannoma
Harnessing plasticity to treat brain tumours (Study ID: 37315) Brain tumours are hard to treat. They are not very sensitive to chemotherapy and radiotherapy. The main therapy is brain surgery to remove the tumour. Even if the... read more
Anaplastic astrocytoma
Anaplastic glioma
Anaplastic oligodendroglioma
Astrocytoma
Glioblastoma
Glioma
Medulloblastoma
Meningioma
Ependymoma
oligoastrocytoma
Neuroblastoma
Brain metastases
Pituitary
Schwannoma
HSI Neuro Phantom (Study ID: 38815) Successful neurosurgery to remove brain tumours depends on achieving maximal safe tumour removal; avoiding damaging sensitive areas that undertake vital functions and... read more
Schwannoma
Pituitary
Brain metastases
Neuroblastoma
oligoastrocytoma
Ependymoma
Meningioma
Medulloblastoma
Glioma
Glioblastoma
Astrocytoma
Anaplastic oligodendroglioma
Anaplastic glioma
Anaplastic astrocytoma
BT-LIFE – Brain Tumours, Lifestyle Interventions, and Fatigue Evaluations (Study ID: 38936) 'BT-LIFE' stands for “Brain Tumours, Lifestyle Interventions, and Fatigue Evaluation." We aim to see if it is feasible to treat fatigue without using drugs, in... read more

View by brain tumour type: All brain tumour types , Anaplastic astrocytoma, Anaplastic glioma, Anaplastic oligodendroglioma, Astrocytoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Ependymoma, oligoastrocytoma, Neuroblastoma, Brain metastases, Paediatric, Pituitary, Schwannoma